Clinical Trial

Non-inferiority Randomized Controlled Trial of Cognitive Targeted Biopsy Versus Software Targeted Biopsy

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 16, 2024 (before its estimated April 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a randomized controlled and non-inferiority trial in comparison of the cognitive fusion targeted biopsy between the software-based fusion targeted biopsy in the detection rate of clinically significant cancer in men suspected to have a PCa.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2020-02-13; most recent amendment 2024-08-14.
Status change: Not Yet Recruiting → Recruiting 2024-08-14
Trial Details
NCT Number NCT04271527
Lead Sponsor Shanghai East Hospital
Collaborators: Peking Union Medical College Hospital, First Affiliated Hospital Xi'an Jiaotong University, Qilu Hospital of Shandong University, The First Affiliated Hospital of Zhengzhou University, Zibo Central Hospital, Shandong Provincial Hospital, The First Affiliated Hospital of Henan university of CM, Second Affiliated Hospital of Xi'an Jiaotong University, Peking University First Hospital, The University of Hong Kong-Shenzhen Hospital
Conditions Prostate Cancer
Enrollment 626 participants
Start Date 2024-02-20
Primary Completion 2025-04-01 (estimated)
Study Completion 2025-05-14 (estimated)
Updated on ClinicalTrials.gov 2024-08-16